Diagnos Laboratorium Utama PT Tbk (DGNS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.008x

Based on the latest financial reports, Diagnos Laboratorium Utama PT Tbk (DGNS) has a cash flow conversion efficiency ratio of 0.008x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.52 Billion ≈ $88.96K USD) by net assets (Rp194.00 Billion ≈ $11.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Diagnos Laboratorium Utama PT Tbk to measure how much of total assets are equity-financed.

Diagnos Laboratorium Utama PT Tbk - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Diagnos Laboratorium Utama PT Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Diagnos Laboratorium Utama PT Tbk earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Diagnos Laboratorium Utama PT Tbk Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diagnos Laboratorium Utama PT Tbk ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
First Au Ltd AU:FAU	-0.443x
Naos Ex-50 Opportunities Company Ltd AU:NAC	0.047x
FAWER Automotive Parts Ltd Co SHE:200030	0.027x
Trigon Metals Inc V:TM	0.195x
Haily Group Bhd KLSE:0237	0.070x
3R Games SA WAR:3RG	0.036x
Matichon Public Company Limited BK:MATI	-0.002x
Polwax SA WAR:PWX	-0.320x

Annual Cash Flow Conversion Efficiency for Diagnos Laboratorium Utama PT Tbk (2017–2024)

The table below shows the annual cash flow conversion efficiency of Diagnos Laboratorium Utama PT Tbk from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Diagnos Laboratorium Utama PT Tbk.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rp196.13 Billion ≈ $11.49 Million	Rp27.30 Billion ≈ $1.60 Million	0.139x	+106.49%
2023-12-31	Rp195.59 Billion ≈ $11.46 Million	Rp13.18 Billion ≈ $772.50K	0.067x	+335.77%
2022-12-31	Rp210.43 Billion ≈ $12.33 Million	Rp-6.02 Billion ≈ $-352.51K	-0.029x	-109.80%
2021-12-31	Rp201.80 Billion ≈ $11.82 Million	Rp58.87 Billion ≈ $3.45 Million	0.292x	+10.19%
2020-12-31	Rp99.07 Billion ≈ $5.80 Million	Rp26.23 Billion ≈ $1.54 Million	0.265x	+9.86%
2019-12-31	Rp46.46 Billion ≈ $2.72 Million	Rp11.20 Billion ≈ $656.06K	0.241x	-62.25%
2018-12-31	Rp13.27 Billion ≈ $777.31K	Rp8.47 Billion ≈ $496.20K	0.638x	+388.54%
2017-12-31	Rp3.22 Billion ≈ $188.58K	Rp-712.00 Million ≈ $-41.72K	-0.221x	--

About Diagnos Laboratorium Utama PT Tbk

JK:DGNS Indonesia Diagnostics & Research

Market Cap

$16.99 Million

Rp290.00 Billion IDR

Market Cap Rank

#25573 Global

#553 in Indonesia

Share Price

Rp232.00

Change (1 day)

-0.85%

52-Week Range

Rp140.00 - Rp328.00

All Time High

Rp1408.74